Formulation and evaluation of multilamellar vesicles ropivacaine in pain management
Hao-Wen Kao,1 Yi-Yu Lin,1 Walter J Gwathney,1 Keelung Hong1,2 1TLC Biopharmaceuticals, Inc., South San Francisco, CA 94080, USA; 2Taiwan Liposome Company, Ltd., Taipei 11503, TaiwanCorrespondence: Yi-Yu LinTLC Biopharmaceuticals, Inc., South San Francisco, CA 94080, USATel +1 650 872 8816Fax +1 650...
Guardado en:
Autores principales: | Kao HW, Lin YY, Gwathney WJ, Hong K |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d6f1b88b9cde4917ab2fe967f537c2aa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
An efficient and long-acting local anesthetic: ropivacaine-loaded lipid-polymer hybrid nanoparticles for the control of pain
por: Li A, et al.
Publicado: (2019) -
Long-term effect of ropivacaine nanoparticles for sciatic nerve block on postoperative pain in rats
por: Wang Z, et al.
Publicado: (2016) -
Ropivacaine: An Unusual Cause of Neuroleptic Malignant-Like Syndrome
por: Miguel Santos, et al.
Publicado: (2021) -
Supraclavicular block with Mepivacaine vs Ropivacaine, their impact on postoperative pain: a prospective randomised study
por: Irén Sellbrant, et al.
Publicado: (2021) -
Circadian Variation in the Median Effective Dose of Epidural Ropivacaine for Labor Analgesia
por: Jiali Deng, et al.
Publicado: (2021)